Wenjie Zheng

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 5

Top Topics

Long Non Coding Rna

Systemic Lupus Erythematosus

Cancer Stem Cells

Top Venues

Cell & bioscience

Disease markers

Journal of translational medicine

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Mengqi Zhu, Mengna Wu, Saiyan Bian, Qianqian Song, Mingbing Xiao, Hua Huang, Li You, Jianping Zhang, Jie Zhang, Chun Cheng, Wenkai Ni, Wenjie Zheng
DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT/mTOR signaling and UBE2C-mediated P53 ubiquitination. Cell & bioscience 11 (1) (2021)
Wenjie Zheng, Min Yao, Mengna Wu, Junling Yang, Dengfu Yao, Li Wang
Secretory clusterin promotes hepatocellular carcinoma progression by facilitating cancer stem cell properties via AKT/GSK-3β/β-catenin axis. Journal of translational medicine 18 (1) (2020)
Jie Zhang, Chaoyu Gu, Qianqian Song, Mengqi Zhu, Yuqing Xu, Mingbing Xiao, Wenjie Zheng
Identifying cancer-associated fibroblasts as emerging targets for hepatocellular carcinoma. Cell & bioscience 10 (1) (2020)
Jie Zhang, Qianqian Song, Jinxia Liu, Lina Lu, Yuqing Xu, Wenjie Zheng
Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma. Disease markers 2019 (2019)
Chen Dong, Qiao Zhou, Ting Fu, Rui Zhao, Junling Yang, Xiaoli Kong, Zhongyuan Zhang, Chi Sun, Yanfeng Bao, Xinyu Ge, Zexu Zhang, Zhimin Lu, Jing Li, Wenjie Zheng, Zhifeng Gu, Juan Ji
Circulating Exosomes Derived-miR-146a from Systemic Lupus Erythematosus Patients Regulates Senescence of Mesenchymal Stem Cells. BioMed research international 2019 (2019)